Argitalpenak (28) JOSÉ MANUEL PORRES ARACAMA argitalpenak

2018

  1. Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design: The ASAF trial: ablation of sympathetic atrial fibrillation

    Clinical Research in Cardiology, Vol. 107, Núm. 7, pp. 539-547

2016

  1. Large genomic imbalances in Brugada syndrome

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Candida albicans endocarditis in a patient with an implantable cardioverter defibrillator (ICD)

    Enfermedades Infecciosas y Microbiologia Clinica Monografias

  2. Comprehensive genetic characterization of a Spanish Brugada syndrome cohort

    PLoS ONE, Vol. 10, Núm. 7

  3. Endocarditis por candida albicans en paciente portadora de dai

    Enfermedades Infecciosas y Microbiologia Clinica

2013

  1. Adenosina y proarritmia en pacientes con síndrome de Wolf-Parkinson-White

    Medicina Intensiva, Vol. 37, Núm. 2, pp. 125

  2. Cardiac resynchronization therapy: 6 year experience of a comprehensive follow-up protocol

    Medicina Intensiva

2012

  1. Cardiac 'resynchronization' by a left lateral accessory pathway

    Cardiology Journal, Vol. 19, Núm. 5, pp. 536-538

2008

  1. Application of a clinical magnet over implantable cardioverter defibrillators: Is it safe and useful?

    PACE - Pacing and Clinical Electrophysiology, Vol. 31, Núm. 12, pp. 1641-1645

2006

  1. Pacientes críticos portadores de marcapasos y desfibriladores automáticos

    Medicina Intensiva, Vol. 30, Núm. 6, pp. 280-283

2004

  1. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome

    PACE - Pacing and Clinical Electrophysiology, Vol. 27, Núm. 11, pp. 1563-1565

2003

  1. Poisoning due to tricyclic antidepressants associated with Brugada syndrome [1]

    Medicina Intensiva

  2. Prevalence of venous thrombosis in relation to endocavitary pacemaker leads. Prophylactic treatment with low-dose oral anticoagulation therapy

    Medicina Intensiva, Vol. 27, Núm. 8, pp. 531-537

  3. Sudden cardiac death and MADIT II

    Medicina Intensiva, Vol. 27, Núm. 6, pp. 410-416

2002

  1. Fever unmasking the Brugada syndrome

    PACE - Pacing and Clinical Electrophysiology, Vol. 25, Núm. 11, pp. 1646-1648

  2. Narrow QRS tachycardia that accelerates spontaneously. What is the explanation?

    PACE - Pacing and Clinical Electrophysiology, Vol. 25, Núm. 2, pp. 206-208

2000

  1. Ablation of the atrio-ventricular junction in atrial fibrillation refractory to drug therapy

    Medicina Intensiva, Vol. 24, Núm. 1, pp. 8-13

1998

  1. Ablacion eficaz por radiofrecuencia de haz anomalo izquierdo durante fibrilacion auricular sostenida

    Medicina Intensiva, Vol. 22, Núm. 9, pp. 432-435

1997

  1. TAQUICARDIA IDIOPATICA DEL VENTRICULO DERECHO. OPCIONES TERAPEUTICAS

    Medicina Intensiva, Vol. 21, Núm. 9, pp. 395-398

  2. Taquicardias ventriculares. Ablacion mediante radiofrecuencia

    Medicina Intensiva